Frederick v. Calbio Pharmaceuticals

89 Cal. App. 3d 49, 152 Cal. Rptr. 292, 1979 Cal. App. LEXIS 1358
CourtCalifornia Court of Appeal
DecidedJanuary 31, 1979
DocketCiv. 53928
StatusPublished
Cited by24 cases

This text of 89 Cal. App. 3d 49 (Frederick v. Calbio Pharmaceuticals) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Frederick v. Calbio Pharmaceuticals, 89 Cal. App. 3d 49, 152 Cal. Rptr. 292, 1979 Cal. App. LEXIS 1358 (Cal. Ct. App. 1979).

Opinion

*52 Opinion

POTTER, Acting P. J.

Plaintiffs Rose Ellen Frederick, Alan Frederick and Leslie Frederick appeal from the judgment dismissing their complaint against defendant Calbio Pharmaceuticals for damages for the wrongful death of William Frederick. The judgment was entered after defendant’s demurrer was sustained with 30 days’ leave to amend, and plaintiffs failed within that time to file an amended pleading.

The sole ground of demurrer was “[t]hat the complaint, and each and every cause of action thereof, is barred by the statute of limitations, namely, ¡Section 340(3) of the California Code of Civil Procedure.”

The complaint charged each defendant with having “negligently, carelessly and recklessly” caused a drug to be distributed “for experimental and investigational use without establishing the necessary safeguards and controls to prevent their distributees from administering said drug to patients,” and that defendants “knew, or should [have] known that incident to the use of [said drug] was the risk of Thrombotic Complications, Myocardial Infarction and Blood Clotting.” Massive doses of the drug were administered to decedent “from on or about October 28, 1974 to January 27, 1975.” On January 31, 1975, “as a direct and proximate result of the said negligence or acts and omissions of Defendants, the decedent suffered a Hemorrhagic Thrombus extending into the Anterior Descending Coronaiy Artery from which decedent died.”

The allegations of the complaint with respect to discovery of the connection between defendants’ negligence and the death of the decedent were all contained in paragraph 13. It read as follows:

“The facts alleged herein as the cause of death of decedent did not become known to the Plaintiffs, neither could they by the exercise of reasonable diligence have become aware of said facts, until after the Food and Drug Administration of the United States on or about August 13, 1976 issued a press release that the said drug also known as Triazure was being recalled due to incidents of Thrombosis and Blood Clotting attributed to use of said drug and it was reported that one patient died and another developed Arterial Thrombosis which resulted in amputation of the left lower leg and other incidents which were serious and constituted a pattern of danger to patients undergoing therapy with this drug.”

*53 The memorandum of points and authorities in support of the demurrer did not question the sufficiency of the allegations of paragraph 13 to show circumstances excusing delayed discovery of the cause of decedent’s death. Instead, defendant relied exclusively on the proposition that the one-year limitation period for wrongful death actions (other than “causes of action for ‘professional negligence’ against ‘health care providers’ as those terms are defined in § 340(5) of the Code of Civil Procedure”) “must be instituted within one year from the date of death.” Defendant argued: “There is no reported case involving death where the exception[ 1 ] delaying accrual of the cause of action was permitted. If the Court permits a wrongful death case to be asserted against defendant herein because (as is alleged in paragraphs 13 and 14 of the complaint) the plaintiffs did not learn of the hazards of Azaribine prior to an FDA press release dated August 13, 1976, then there would be no viable limitations period available to a drug manufacturer.”

The order sustaining the demurrer read: “Demurrer is sustained on ground set forth therein.”

Contentions

Plaintiffs contend that (1) the one-year limitation specified in Code of Civil Procedure section 340, subdivision 3, for wrongful death actions does not commence to run until the wrongful death heirs discover or should have discovered their injury in the form of the death of their decedent and its negligence cause, and (2) the complaint pleaded sufficient facts to justify delayed accrual. Defendant contends that (1) wrongful death actions (other than those for “professional negligence” against “health care providers”) must in all events be brought within one year from the date of death, and (2) the allegations of the complaint are inadequate to justify delayed discovery.

Discussion

Summary

A wrongful death action against a manufacturer based upon negligence or products liability comes within the rule that a plaintiff who *54 is “blamelessly ignorant” of his cause of action is not barred by his delay in bringing suit; the one-year period to file suit, therefore, commences on the date on which the plaintiff discovers, or should have discovered, his injury in the form of the death of his decedent and its tortious cause. The allegations of the complaint adequately pleaded the circumstances under which plaintiffs discovered the negligent cause of the decedent’s injury. Additional facts might have been pleaded explaining the conclusory allegation that plaintiffs could not “by the exercise of reasonable diligence have become aware of said facts” but defendant did not urge that deficiency as the basis for its demurrer. Consequently, plaintiffs had no meaningful opportunity to amend to meet this objection, and the judgment should not be affirmed on that basis.

The One-Year Limitation for Wrongful Death Actions Does Not Commence to Run Until Wrongful Death Heirs Have Discovered, or Should Have Discovered, Their Injury in the Form of Death of Their Decedent and Its Negligent Cause

Defendant’s contention that the one-year statute of limitations on wrongful death actions provided by Code of Civil Procedure section 340, subdivision 3, in all events commences to run on the death of the decedent is contrary to well-established California authority and is unsupported by any of the authorities cited.

Defendant’s reliance on the annotation in (1964) 97 A.L.R.2d 1151 is misplaced. Though that annotation states the general rule that “the action must be instituted within the statutory period from the date of death” (id., at p. 1154), the scope of the annotation is stated as follows (id, at p. 1153): “The aim is only to elucidate questions as to when the period of limitation normally begins to run. No attempt is made to cover matters of disability or to treat special provisions delaying the normal initiation of the limitation period under particular circumstances.” (Italics added.)

The same is true of Frost v. State of California (1966) 247 Cal.App.2d 378, 382 [55 Cal.Rptr. 652]; it merely stated that a “cause of action for wrongful death arose on the date of death” under the circumstances of that case, which did not involve any claim of delayed discovery of the cause of the death.

Except in the case of wrongful death claims for “professional negligence” against “a health care provider,” governed by Code of Civil *55 Procedure section 340.5, 2

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Thompson v. County of Riverside CA4/1
California Court of Appeal, 2025
Grano v. Sodexo, Inc.
S.D. California, 2020
Thompson v. Walgreen CA1/1
California Court of Appeal, 2014
Lyles v. State
62 Cal. Rptr. 3d 696 (California Court of Appeal, 2007)
Clark v. Lovelace Health Systems, Inc.
2004 NMCA 119 (New Mexico Court of Appeals, 2004)
Norgart v. Upjohn Co.
981 P.2d 79 (California Supreme Court, 1999)
Miles v. Ashland Chemical Co.
410 S.E.2d 290 (Supreme Court of Georgia, 1991)
Moreno v. Sterling Drug, Inc.
787 S.W.2d 348 (Texas Supreme Court, 1990)
DiMedio v. Consolidated Rail Corp.
649 F. Supp. 1340 (D. Delaware, 1986)
Trimper v. Porter-Hayden
501 A.2d 446 (Court of Appeals of Maryland, 1985)
Kensinger v. Abbott Laboratories
171 Cal. App. 3d 376 (California Court of Appeal, 1985)
McGOWAN v. UNIVERSITY OF SCRANTON
759 F.2d 287 (Third Circuit, 1985)
Hanebuth v. Bell Helicopter International
694 P.2d 143 (Alaska Supreme Court, 1984)
Prescott v. United States
523 F. Supp. 918 (D. Nevada, 1981)
Vecchione v. Carlin
111 Cal. App. 3d 351 (California Court of Appeal, 1980)
Leaf v. City of San Mateo
104 Cal. App. 3d 398 (California Court of Appeal, 1980)

Cite This Page — Counsel Stack

Bluebook (online)
89 Cal. App. 3d 49, 152 Cal. Rptr. 292, 1979 Cal. App. LEXIS 1358, Counsel Stack Legal Research, https://law.counselstack.com/opinion/frederick-v-calbio-pharmaceuticals-calctapp-1979.